Treating Hypertension in Older Adults

This article discusses the efficacy, use and adverse effects of antihypertensive drug therapy in older adults. Numerous double-blind, randomized, placebo-controlled studies have demonstrated that antihypertensive drug therapy reduces cardiovascular events in older adults. All antihypertensive drugs may predispose older patients to the development of symptomatic orthostatic hypotension and postprandial hypotension, and syncope or falls. Adverse effects of diuretics, β-adrenergic receptor antagonists, ACE inhibitors, angiotensin receptor antagonists, calcium channel antagonists, α-adrenergic receptor antagonists, centrally acting drugs and direct vasodilators are discussed. The adverse effects depend on the antihypertensive drugs used, the doses used, the co-morbidities present in older patients taking these drugs and drug-drug interactions.

[1]  W. Aronow,et al.  Prevalence of adequate blood pressure control in self-pay or Medicare patients versus Medicaid or private insurance patients with systemic hypertension followed in a university cardiology or general medicine clinic. , 2004, The American journal of cardiology.

[2]  Keith C. Norris,et al.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. , 2001, JAMA.

[3]  H. A. Cameron,et al.  The lupus syndrome induced by hydralazine: a common complication with low dose treatment. , 1984, British medical journal.

[4]  W. Aronow,et al.  Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease. , 2001, The American journal of cardiology.

[5]  L. Rubenstein,et al.  Postural Hypotension in the Elderly , 1984, Journal of the American Geriatrics Society.

[6]  W. Aronow,et al.  Secondary hypertension: current diagnosis and treatment. , 2008, International journal of cardiology.

[7]  W. Aronow Treatment of Atrial Fibrillation and Atrial Flutter: Part II , 2008, Cardiology in review.

[8]  J. Wei,et al.  Postprandial reduction in blood pressure in the elderly. , 1983, The New England journal of medicine.

[9]  W. Hazzard,et al.  Principles of Geriatric Medicine and Gerontology , 2003 .

[10]  W. Aronow,et al.  Prevalence of peripheral arterial disease and its correlation with risk factors for peripheral arterial disease in elderly patients in a long-term health care facility. , 1988, The American journal of cardiology.

[11]  W. Aronow,et al.  Adequacy of control of hypertension in an academic nursing home. , 2007, Journal of the American Medical Directors Association.

[12]  W. Aronow,et al.  Cardiovascular Drug Therapy in the Elderly , 2007, Cardiology in review.

[13]  A. Hofman,et al.  The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial , 2003, Journal of hypertension.

[14]  T. Hanslik,et al.  Metabolic Adverse Reactions to Diuretics , 1995, Drug safety.

[15]  B. Palmer Renal dysfunction complicating the treatment of hypertension. , 2002, The New England journal of medicine.

[16]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[17]  Mehra,et al.  A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. , 1990, Circulation.

[18]  H. Kennedy,et al.  Beta-blocker therapy in the cardiac arrhythmia suppression trial , 1994 .

[19]  P. Vokonas,et al.  Epidemiology of Coronary Heart Disease in the Elderly , 2008 .

[20]  R. Hajjar Commentary on "Embracing complexity: A consideration of hypertension in the very old". , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[21]  S. Yusuf,et al.  Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.

[22]  M. Rich,et al.  Disability and Frailty in Older Patients with Cardiovascular Disease , 2008 .

[23]  W. Cushman,et al.  Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. , 2000, Hypertension.

[24]  Bernard J. Gersh,et al.  Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention , 2007, Circulation.

[25]  W. Aronow,et al.  Effect of beta blockers alone, of angiotensin-converting enzyme inhibitors alone, and of beta blockers plus angiotensin-converting enzyme inhibitors on new coronary events and on congestive heart failure in older persons with healed myocardial infarcts and asymptomatic left ventricular systolic dysf , 2001, The American journal of cardiology.

[26]  J. Scott,et al.  Diuretic induced gout: a multifactorial condition. , 1992, Annals of the rheumatic diseases.

[27]  J. Crowley,et al.  Minoxidil-associated pericarditis and fatal cardiac tamponade. , 1985, The Western journal of medicine.

[28]  R. D'Agostino,et al.  The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. , 1987, Circulation.

[29]  W. Aronow,et al.  Postprandial Hypotension in 499 Elderly Persons in a Long‐Term Health Care Facility , 1994, Journal of the American Geriatrics Society.

[30]  B. Pitt,et al.  Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .

[31]  W. Aronow,et al.  Association of Postprandial Hypotension With Incidence of Falls, Syncope, Coronary Events, Stroke, and Total Mortality at 29‐Month Follow‐Up in 499 Older Nursing Home Residents , 1997, Journal of the American Geriatrics Society.

[32]  W. Aronow,et al.  Decrease in mortality by propranolol in patients with heart disease and complex ventricular arrhythmias is more an anti-ischemic than an antiarrhythmic effect. , 1994, The American journal of cardiology.

[33]  W. Aronow,et al.  Treatment of hypertension and prevention of ischemic stroke , 2004, Current cardiology reports.

[34]  J. Goodwin Embracing complexity: A consideration of hypertension in the very old. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[35]  R. Vasan,et al.  The progression from hypertension to congestive heart failure. , 1996, JAMA.

[36]  W. Aronow,et al.  Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and diabetes mellitus. , 2001, The American journal of cardiology.

[37]  Eli Warnock,et al.  The effect of diltiazem on mortality and reinfarction after myocardial infarction. , 1989, The New England journal of medicine.

[38]  J. Cohn,et al.  Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group. , 1997, Circulation.

[39]  W. Aronow,et al.  Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[40]  D. Vidt,et al.  Major cardiovascular events in hypertensive patients randomized to doxazosin versus chlorthalidone , 2000 .

[41]  D. Sica,et al.  Diuretic Combinations in Refractory Oedema States , 1996 .

[42]  W. Hall,et al.  Cough and Angioneurotic Edema Associated with Angiotensin-Converting Enzyme Inhibitor Therapy , 1992, Annals of Internal Medicine.

[43]  C M O'Connor,et al.  Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. , 1996, The New England journal of medicine.

[44]  J. Potter,et al.  Cardiovascular Disease in the Elderly Patient , 1994 .

[45]  W. Aronow,et al.  Risk factors for new atherothrombotic brain infarction in 664 older men and 1,488 older women. , 1996, The American journal of cardiology.

[46]  J. Guralnik,et al.  Long‐Term Survival and Use of Antihypertensive Medications in Older Persons , 1995, Journal of the American Geriatrics Society.

[47]  Barry R. Davis,et al.  Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. , 2000, JAMA.

[48]  N. Madias,et al.  Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. , 1983, The New England journal of medicine.

[49]  W. Aronow,et al.  Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors. , 1997, The American journal of cardiology.

[50]  V. Hirth,et al.  Age-related bias in the management of hypertension: a national survey of physicians' opinions on hypertension in elderly adults. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.

[51]  W. Aronow,et al.  Prevalence of postural hypotension in elderly patients in a long-term health care facility. , 1988, The American journal of cardiology.

[52]  Li-sheng Liu,et al.  Treatment of hypertension in patients 80 years of age or older. , 2008, The New England journal of medicine.

[53]  W. Aronow,et al.  Simultaneous Measurements of Blood Pressures in Right and Left Brachial Arteries , 2004, Cardiology in review.

[54]  W. Aronow,et al.  Drug Treatment of Hypertension in Older Persons in an Academic Hospital‐Based Geriatrics Practice , 1999, Journal of the American Geriatrics Society.

[55]  W. Aronow Etiology, Pathophysiology, and Treatment of Atrial Fibrillation: Part 1 , 2008, Cardiology in review.

[56]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[57]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[58]  W. Aronow,et al.  Angina in the Elderly , 2008 .

[59]  W. Aronow,et al.  Incidence of new coronary events in older persons with prior myocardial infarction and systemic hypertension treated with beta blockers, angiotensin-converting enzyme inhibitors, diuretics, calcium antagonists, and alpha blockers. , 2002, The American journal of cardiology.

[60]  B. Pitt,et al.  The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .

[61]  R. Toto,et al.  Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis. , 1991, Annals of internal medicine.

[62]  W. Aronow The heart and thyroid disease. , 1995, Clinics in geriatric medicine.

[63]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.

[64]  W. Aronow,et al.  Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites. , 1999, The American journal of cardiology.

[65]  B. Davis,et al.  The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience. , 2001, Controlled clinical trials.

[66]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[67]  W. Aronow,et al.  Risk Factors for Symptomatic Peripheral Arterial Disease in Older Persons in an Academic Hospital‐Based Geriatrics Practice , 2000, Journal of the American Geriatrics Society.

[68]  W. Aronow,et al.  Risk factors for new coronary events in a large cohort of very elderly patients with and without coronary artery disease. , 1996, The American journal of cardiology.

[69]  R Peto,et al.  Effect of Age and High Blood Pressure on Barorefiex Sensitivity in Man , 1971, Circulation research.

[70]  R. Soriano Dizziness and Syncope , 2007 .

[71]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[72]  W. Aronow,et al.  Congestive heart failure, coronary events and atherothrombotic brain infarction in elderly blacks and whites with systemic hypertension and with and without echocardiographic and electrocardiographic evidence of left ventricular hypertrophy. , 1991, The American journal of cardiology.

[73]  S. Nattel,et al.  Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group. , 1991, Circulation.

[74]  Alan C. Wilson,et al.  Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. , 2005, The American journal of cardiology.